Abuse of propofol by anesthesia providers: The case for re-classification as a controlled substance

Journal of Addictions Nursing

Volumn 22, Issue 1-2, 2011, Pages 57-62

  Stocks, Gregory ^a,b  

^a American Association of Nurse Anesthetists   (United States)

^b NONE   (United States)

Author keywords

Drugs Illicit Prescribed; Impaired Practice; Nurse Peer Nursing Student; Policy; Substance Abuse

Indexed keywords

EID: 79953087295     PISSN: 10884602     EISSN: 15487148     Source Type: Journal    
DOI: 10.3109/10884602.2010.545091     Document Type: Article

References (30)

1. AANA. (1984). AANA position statement 1.7: Substance misuse and chemical dependency. Retrieved September 1, 2009, from American Association of Nurse Anesthetists: Practice Documentst/position statement1 7pdf
2. AANA. (2000). AANA's peer assistance: Overview and FAQs. Retrieved September 1, 2009, from American Association of Nurse Anesthetists: http://www.aana.com/Resources.aspx?ucNavMenu TSMenuTargetID=154&ucNavMenu TSMenuTargetType=4&ucNavMenu TSMenuID=6&id=6192
3. AANA. (2009, June). Position statement 2.14 securing propofol. Retrieved September 1, 2009, from American Association of Nurse Anesthetists:
4. Arain, S. R., & Ebert, T. J. (2002). The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesthesia Analg 2002, 95, 461-466. (Pubitemid 34793121)
5. Astra-Zeneca. (2006). Global prescribing information and international prescribing notes. Retrieved October 17, 2009, from Anaesthesia-AZ:
6. Bonnet, U., Harkner, J., & Sherbaim, N. (2008). A case report of propofol dependence in a physician. Journal of Psychoactive Drugs, 40, 215-217.
7. Booth, J. V., Grossman, D., Moore, J., Linberger, C., Reynolds, J. D., Reves, J. G., et al. (2002). Substance abuse among physicians: A survey of academic anesthesia programs. Anesthesia & Analgesia, 95, 1024-1030.
8. Bryson, E. O., & Silverstein, J. H. (2008). Addiction and substance abuse in anesthesiology. Anesthesiology, 109(5), 905-917.
9. Chao, J., & Nestler, E. J. (2004). Molecular neurobiology of drug addiction. Annual Review of Medicine, 55, 113-132. (Pubitemid 38316718)
10. Drug Enforcement Administration, Department of Justice. (2010, October 27). Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule. Federal Register, 75(5), 66195-199.
11. Eger, E. L. (2004). Characteristics of anesthetic agents used for induction. American Journal of Health System Pharmacy, 53, 61.
12. FDA. (n.d.). Controlled substances Act: PART B-AUTHORITY TO CONTROL; STANDARDS AND SCHEDULES. Retrieved September 1, 2009, from Food and Drug Administration:
13. Follette, J. W., & Farley, W. J. (1992). Anesthesiologist addicted to propofol. Anesthesiology, 77, 817-819.
14. Fritz, G. A., & Niemczyk, W. E. (2002). Propofol dependency in a lay person. Anesthesiology, 96, 505-506. (Pubitemid 34121763)
15. Gupta, A., Stierer, T., Sakima, N., Parker, S. D., Zuckerman, R., & Fleisher, L. A. (2004). Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: A systematic review. Anesthesia & Analgesia, 98, 632-641. (Pubitemid 38252650)
16. Iwersen-Bergmann, S., Rosner, P., Kühnau, H. C., Junge, M., & Schmoldt, A. (2001). Death after excessive propofol abuse. International Journal of Legal Medicine, 114, 248-251. (Pubitemid 32367157)
17. Koob, G.,(2009). Dynamics of neuronal circuits in addiction: Reward, antireward, and emotional memory. Pharmacopsychiatry, 42(Suppl 1), S32-41.
18. Kranioti, E. F.,Mavroforou, A., Mylonakis, P.,&Michalodimitrakis,M. (2007). Lethal self administration of propofol (Diprivan). A case report and review of the literature. Forensic Sci International, 157, 56-58. (Pubitemid 46412674)
19. LeSage, M. G., Stafford, D., & Glowa, J. R. (2000). Abuse liability of the anesthetic propofol: Self-administration of propofol in rats under fixed-ratio schedules of drug delivery. Psychopharmacology (Berl), 153, 149-154.
20. Li, K.-Y., Cheng, X., Xiong, M., Delphin, E., & Ye, J. H. (2008). Nanomolar propofol stimulates glutamate transmission to dopamine neurons: A possible mechanism of abuse potential? Journal of Pharmacology and Experimental Therapeutics, 325, 165-174. (Pubitemid 351439179)
21. Marcus, A.,(2009). Anesthesiologists see more scrutiny in wake of Jackson's death. Retrieved October 17, 2009 from Anesthesiology News: . anesthesiologynews.com/index.asp?section id=175&show=dept&article id=13538.
22. Pain, L., Gobaille, S., Schleef, C., Aunis, D., & Oberling, P. (2002). In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesthesia & Analgesia, 95, 915-919.
23. Roussin, A., Lapeyre-Mestre, M., & Montastruc, J. (2007). Pharmacological and clinical evidences on the potential for abuse and dependence of propofol- a review of the literature. Fundamental and Clinical Pharmacology, 21, 459-465. (Pubitemid 47404323)
24. Roussin, A., Mirepoix, M., Lassabe, G., Dumestre-Toulet, V., Gardette, V., Montastruc, J. L., et al. (2006). Death related to a recreational abuse of propofol at therapeutic dose range. British Journal of Anaesthesia, 98, 268. (Pubitemid 44295724)
25. Stocks, G.,(2009). AANA peer assistance update. North Carolina Association of Nurse Anesthetists,General Session Presentation, October 31, 2009.
26. Wandel, C., Neff, S., Bohrer, H., Browne, A., Motsch, J., & Martin, E. (1995). Recovery characteristics following anaesthesia with sevoflurane or propofol in adults undergoing out-patient surgery. European Journal Clinical Pharmacology, 48, 185-188.
27. Ward, C. (1992). Substance abuse. Now, and for some time to come. Anesthesiology, 77, 619-622.
28. Wischmeyer, P. E., Johnson, B. R., Wilson, J. E., Dingmann, C., Bachman, H. M., Roller, E., et al. (2007). A survey of propofol abuse in academic anesthesia programs. Anesthesia & Analgesia, 105, 10666-10671.
29. Zachny, J. P., Lichtor, J. L., Thompson,W., & Apfelbaum, J. L. (1993a). Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesthesia & Analgesia, 77, 544-552. (Pubitemid 23263527)
30. Zachny, J. P., Lichtor, J. L., Zaragoza, J. G., Coalson, D. W., Uitvlugt, A. M., Flemming, D. C., Binstock, W. B., Cutter, T., Apfelbaum, & J. L. (1993b). Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug Alcohol Depend., 32, 45-57. (Pubitemid 23113270)